Area of research
Pathology and Forensic Medicine · Genetics
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Viral-associated cancers and disorders, and Immunodeficiency and Autoimmune Disorders.
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.
Clonal hematopoiesis of indeterminate potential and risk of immune thrombocytopenia
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker
Supplementary Table S3 from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies
Supplementary Methods S1 from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies
Assessing an eHealth Intervention on Quality of Life in Patients With Chronic Lymphocytic Leukemia and Myelodysplastic Syndromes: The MyPal Randomized Controlled Trial.
Supplementary Table S1 from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies
Supplementary Table S2 from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies
Clonal hematopoiesis of indeterminate potential and risk of neurodegenerative diseases
Clonal hematopoiesis of indeterminate potential and risk of neurodegenerative diseases
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study
Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma.
Potential for Cure by Stage across the Cancer Spectrum in the United States.
Health-related quality of life and supportive care needs in young adult cancer survivors-a longitudinal population-based study.
Table S1 from Potential for Cure by Stage across the Cancer Spectrum in the United States
Table S2 from Potential for Cure by Stage across the Cancer Spectrum in the United States
Figure S2 from Potential for Cure by Stage across the Cancer Spectrum in the United States
Figure S1 from Potential for Cure by Stage across the Cancer Spectrum in the United States
Data from Potential for Cure by Stage across the Cancer Spectrum in the United States
Figure S2 from Potential for Cure by Stage across the Cancer Spectrum in the United States
Table S1 from Potential for Cure by Stage across the Cancer Spectrum in the United States
Figure S1 from Potential for Cure by Stage across the Cancer Spectrum in the United States
Table S2 from Potential for Cure by Stage across the Cancer Spectrum in the United States
Data from Potential for Cure by Stage across the Cancer Spectrum in the United States
Figure S3 from Potential for Cure by Stage across the Cancer Spectrum in the United States
Figure S3 from Potential for Cure by Stage across the Cancer Spectrum in the United States
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma
Novel precision medicine approaches and treatment strategies in hematological malignancies
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma.
Novel precision medicine approaches and treatment strategies in hematological malignancies.